344 related articles for article (PubMed ID: 9484840)
41. TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins.
Wilbanks AM; Mahajan S; Frank DA; Druker BJ; Gilliland DG; Carroll M
Exp Hematol; 2000 May; 28(5):584-93. PubMed ID: 10812249
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer.
Widschwendter A; Tonko-Geymayer S; Welte T; Daxenbichler G; Marth C; Doppler W
Clin Cancer Res; 2002 Oct; 8(10):3065-74. PubMed ID: 12374673
[TBL] [Abstract][Full Text] [Related]
43. The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals.
Gupta S; Yan H; Wong LH; Ralph S; Krolewski J; Schindler C
EMBO J; 1996 Mar; 15(5):1075-84. PubMed ID: 8605877
[TBL] [Abstract][Full Text] [Related]
44. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs.
Chaturvedi P; Sharma S; Reddy EP
Mol Cell Biol; 1997 Jun; 17(6):3295-304. PubMed ID: 9154828
[TBL] [Abstract][Full Text] [Related]
45. STAT proteins and transcriptional responses to extracellular signals.
Horvath CM
Trends Biochem Sci; 2000 Oct; 25(10):496-502. PubMed ID: 11050435
[TBL] [Abstract][Full Text] [Related]
46. PDGF receptor-to-nucleus signaling of p91 (STAT1 alpha) transcription factor in rat smooth muscle cells.
Yamamoto H; Crow M; Cheng L; Lakatta E; Kinsella J
Exp Cell Res; 1996 Jan; 222(1):125-30. PubMed ID: 8549654
[TBL] [Abstract][Full Text] [Related]
47. The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta.
Saharinen P; Ekman N; Sarvas K; Parker P; Alitalo K; Silvennoinen O
Blood; 1997 Dec; 90(11):4341-53. PubMed ID: 9373245
[TBL] [Abstract][Full Text] [Related]
48. The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways.
Sternberg DW; Tomasson MH; Carroll M; Curley DP; Barker G; Caprio M; Wilbanks A; Kazlauskas A; Gilliland DG
Blood; 2001 Dec; 98(12):3390-7. PubMed ID: 11719379
[TBL] [Abstract][Full Text] [Related]
49. Role of Jak kinases and STATs in cytokine signal transduction.
Leonard WJ
Int J Hematol; 2001 Apr; 73(3):271-7. PubMed ID: 11345192
[TBL] [Abstract][Full Text] [Related]
50. Cytokine receptor-independent, constitutively active variants of STAT5.
Berchtold S; Moriggl R; Gouilleux F; Silvennoinen O; Beisenherz C; Pfitzner E; Wissler M; Stöcklin E; Groner B
J Biol Chem; 1997 Nov; 272(48):30237-43. PubMed ID: 9374508
[TBL] [Abstract][Full Text] [Related]
51. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.
Schindler C; Darnell JE
Annu Rev Biochem; 1995; 64():621-51. PubMed ID: 7574495
[TBL] [Abstract][Full Text] [Related]
52. Tyrosine kinase-mediated cell signalling in the activation of Mytilus hemocytes: possible role of STAT-like proteins.
Canesi L; Betti M; Ciacci C; Citterio B; Pruzzo C; Gallo G
Biol Cell; 2003 Dec; 95(9):603-13. PubMed ID: 14720463
[TBL] [Abstract][Full Text] [Related]
53. Tyr-716 in the platelet-derived growth factor beta-receptor kinase insert is involved in GRB2 binding and Ras activation.
Arvidsson AK; Rupp E; Nånberg E; Downward J; Rönnstrand L; Wennström S; Schlessinger J; Heldin CH; Claesson-Welsh L
Mol Cell Biol; 1994 Oct; 14(10):6715-26. PubMed ID: 7935391
[TBL] [Abstract][Full Text] [Related]
54. Distinct mechanisms of activation of Stat1 and Stat3 by platelet-derived growth factor receptor in a cell-free system.
Vignais ML; Gilman M
Mol Cell Biol; 1999 May; 19(5):3727-35. PubMed ID: 10207096
[TBL] [Abstract][Full Text] [Related]
55. Roscovitine inhibits STAT5 activity and induces apoptosis in the human leukemia virus type 1-transformed cell line MT-2.
Mohapatra S; Chu B; Wei S; Djeu J; Epling-Burnette PK; Loughran T; Jove R; Pledger WJ
Cancer Res; 2003 Dec; 63(23):8523-30. PubMed ID: 14679020
[TBL] [Abstract][Full Text] [Related]
56. Regulation of STAT protein synthesis by c-Cbl.
Blesofsky WA; Mowen K; Arduini RM; Baker DP; Murphy MA; Bowtell DD; David M
Oncogene; 2001 Nov; 20(50):7326-33. PubMed ID: 11704862
[TBL] [Abstract][Full Text] [Related]
57. Activation and association of Stat3 with Src in v-Src-transformed cell lines.
Cao X; Tay A; Guy GR; Tan YH
Mol Cell Biol; 1996 Apr; 16(4):1595-603. PubMed ID: 8657134
[TBL] [Abstract][Full Text] [Related]
58. Activation of STAT3 by the c-Fes protein-tyrosine kinase.
Nelson KL; Rogers JA; Bowman TL; Jove R; Smithgall TE
J Biol Chem; 1998 Mar; 273(12):7072-7. PubMed ID: 9507017
[TBL] [Abstract][Full Text] [Related]
59. Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3.
Dumoutier L; Lejeune D; Hor S; Fickenscher H; Renauld JC
Biochem J; 2003 Mar; 370(Pt 2):391-6. PubMed ID: 12521379
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of cytokine production and interference in IL-2 receptor-mediated Jak-Stat signaling by the hydroxylamine metabolite of sulfamethoxazole.
Hess DA; O'Leary EF; Lee JT; Almawi WY; Madrenas J; Rieder MJ
FASEB J; 2001 Aug; 15(10):1855-7. PubMed ID: 11481253
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
